Table 4.
Impact of dietary oil supplements on serum lipid profile and biomarkers
| Arm | CO | BO | FO | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | Baseline (SD) | Post-oil (SD) | p-value | Baseline (SD) | Post-oil (SD) | p-value | Baseline (SD) | Post-oil (SD) | p-value |
| T. Choles | 183.0 (10.6) | 176.8 (10.0) | 0.25 | 182.0 (7.8) | 171.9 (7.2) | 0.05 | 180.6 (8.3) | 183.0 (10.1) | 0.71 |
| HDL | 46.0 (2.6) | 46.3 (2.6) | 0.73 | 47.6 (2.5) | 48.6 (2.9) | 0.29 | 40.7 (2.8) | 43.6 (2.8) | 0.01 |
| LDL | 102.7 (9.1) | 98.4 (8.8) | 0.53 | 106.3 (7.3) | 96.8 (6.6) | 0.04 | 102.6 (8.3) | 107.9 (9.0) | 0.32 |
| TG* | 172.9 (25.1) | 158.4 (18.8) | 0.38 | 140.2 (10.1) | 132.0 (10.8) | 0.14 | 187.2 (22.0) | 156.8 (14.7) | 0.03 |
| CRP | 2.36 (0.57) | 3.72 (1.00) | 0.41 | 3.03 (0.85) | 3.06 (0.86) | 0.99 | 6.08 (3.19) | 3.59 (1.03) | 0.19 |
| Leptin* | 53.5 (6.8) | 44.2 (5.3) | 0.38 | 33.3 (6.2) | 33.9 (7.4) | 0.82 | 45.1 (11.0) | 40.6 (7.2) | 0.37 |
| Insulin | 20.2 (3.2) | 20.6 (3.3) | 0.83 | 15.4 (2.0) | 17.7 (2.6) | 0.24 | 19.1 (4.5) | 24.6 (6.8) | 0.02 |
| Glucose | 130.0 (9.8) | 130.7 (11.2) | 0.93 | 128.9 (10.8) | 125.9 (7.3) | 0.93 | 133.5 (16.7) | 128.7 (11.1) | 0.33 |
| HOMA-IR* | 5.97 (0.83) | 6.39 (1.08) | 0.6 | 4.77 (0.84) | 5.76 (1.09) | 0.2 | 8.08 (2.76) | 9.19 (3.03) | 0.14 |
| HbAlc | 7.15 (0.34) | 7.07 (0.35) | 0.41 | 6.81 (0.30) | 6.90 (0.27) | 0.83 | 7.42 (0.33) | 7.20 (0.32) | 0.05 |
*p-values derived from log transformed data.
Data are the mean (SD) at baseline and after oil supplementation (combined 4- and 8-week data). Pre – post changes within a supplementation arm that reached statistical significance are shown by a bolded p-value.